Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7067352 | 0.90 | ALDH1A1 (0.44) | ALDH1A1GAATSHR | |
| SCHEMBL5933225 | 0.89 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL5933716 | 0.89 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL1796242 | 0.89 | — | — | |
| SCHEMBL2504826 | 0.85 | — | — | |
| SCHEMBL5932368 | 0.83 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL5911533 | 0.83 | CA2 (0.38) | ALDH1A1TSHR | |
| SCHEMBL197370 | 0.79 | — | — | |
| SCHEMBL2515564 | 0.78 | ALDH1A1 (0.55) | ALDH1A1GAATSHR | |
| SCHEMBL345679 | 0.78 | ALDH1A1 (0.55) | ALDH1A1GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4490176-A | PRINTING INKS, PAINTS; PIGMENT, ALKYLBENZENE SULFONIC ACID, HYDROXYNAPHTHALENE | BASF AKTIENGESELLSCHAFT (DE) | 1984-12-25 | — | — | US | claimed |
| EP-0076995-B1 | LIQUID STABLE PREPARATIONS AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-07-11 | — | — | EP | claimed |
| EP-0043932-B1 | LIQUID, STABLE PREPARATIONS OF PHTHALOCYANINE PIGMENTS OR INDANTHRON AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-04-18 | — | — | EP | claimed |
| EP-0076995-A1 | Liquid stable preparations and their use | BASF Aktiengesellschaft (DE) | 1983-04-20 | — | — | EP | claimed |
| US-4350534-A | Fluid, stable formulations of copper phthalocyanine or indanthrone | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | claimed |
| EP-0043932-A1 | Liquid, stable preparations of phthalocyanine pigments or indanthron and their use | BASF Aktiengesellschaft (DE) | 1982-01-20 | — | — | EP | claimed |
| US-20060100269-A1 | Use of 10-aminoaliphatyl-dibenz[b,f]oxepines for the treatment of degenerative ocular disorders | LAMBROU GEORGE N | 2006-05-11 | — | — | US | disclosed |
| EP-1589963-A1 | USE OF 10-AMINOALIPHATYL-DIBENZ B,F OXEPINES FOR THE TR EATMENT OF DEGENERATIVE OCULAR DISORDERS | Novartis AG (CH) | 2005-11-02 | — | — | EP | disclosed |
| EP-1484191-A1 | REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE | Sony Corporation (JP) | 2004-12-08 | — | — | EP | disclosed |
| WO-2004066993-A1 | USE OF 10-AMINOALIPHATYL-DIBENZ[B,F]OXEPINES FOR THE TREATMENT OF DEGENERATIVE OCULAR DISORDERS | NOVARTIS AG (CH) | 2004-08-12 | — | — | WO | disclosed |
| WO-2003057204-A2 | MODULATION OF IAMT (PIMT OR PCMT) IN IMMUNE SYSTEM | NORDIC BIOSCIENCE A/S (DK) | 2003-07-17 | — | — | WO | disclosed |
| EP-1124903-B1 | CATIONIC AZO-DYES | BASF AG (DE) | 2003-06-25 | — | — | EP | disclosed |
| US-6346609-B1 | DISAZO DYES OR POLYAZO DYES | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-12 | — | — | US | disclosed |
| EP-0090285-B1 | PIGMENT PREPARATIONS AND THEIR USE IN PIGMENTING HELIOGRAPHIC AND LAC COLOURS | BASF Aktiengesellschaft (DE) | 1985-01-16 | — | — | EP | disclosed |
| US-4490176-A | PRINTING INKS, PAINTS; PIGMENT, ALKYLBENZENE SULFONIC ACID, HYDROXYNAPHTHALENE | BASF AKTIENGESELLSCHAFT (DE) | 1984-12-25 | — | — | US | disclosed |
| EP-0076995-B1 | LIQUID STABLE PREPARATIONS AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-07-11 | — | — | EP | disclosed |
| EP-0090285-A2 | Pigment preparations and their use in pigmenting heliographic and lac colours | BASF Aktiengesellschaft (DE) | 1983-10-05 | — | — | EP | disclosed |
| EP-0076995-A1 | Liquid stable preparations and their use | BASF Aktiengesellschaft (DE) | 1983-04-20 | — | — | EP | disclosed |
| US-4350534-A | Fluid, stable formulations of copper phthalocyanine or indanthrone | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | disclosed |
| EP-0043932-A1 | Liquid, stable preparations of phthalocyanine pigments or indanthron and their use | BASF Aktiengesellschaft (DE) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100269-A1 | Use of 10-aminoaliphatyl-dibenz[b,f]oxepines for the treatment of degenerative ocular disorders | DBH, MAOB, AADAT | ALDH1A1 793/4885GAA 3453/4885TSHR 1105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.